Artemis Medicare Services Limited
ARTEMISMED · ISIN: INE025R01021
Artemis Medicare Services Limited is a small cap company in the Healthcare Services sector, listed on the NSE under ISIN INE025R01021.
Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.
CHART
Artemis Medicare Services Limited - growth of ₹100
Growth of ₹100 invested on 2026-05-08, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.
1M
-13.78%
3M
-0.18%
6M
+22.05%
1Y
+21.71%
3Y CAGR
+24.66%
5Y CAGR
-
Earnings (TTM)
LEARN: Revenue and PAT · EPS · P/E
CHART
Artemis Medicare Services Limited - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
Technicals
As of 2026-10-29.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
Corporate Actions
| Ex-Date | Type | Ratio | Details |
|---|---|---|---|
| 2021-09-23 | SPLIT | 0.100000 | FACE VALUE SPLIT (SUB-DIVISION) - FROM RS 10/- PER SHARE TO RE 1/- PER SHARE |
Recent Deals
| Date | Type | Quantity |
|---|---|---|
| 2026-09-25 | BULK | 10,04,061 |
| 2026-09-25 | BULK | 10,04,061 |
Frequently asked questions
What is Artemis Medicare Services Limited's 1-year and 3-year return?
Artemis Medicare Services Limited's 1-year price return is +21.71%. Its 3-year CAGR (annualized return) is +24.66%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.
What is Artemis Medicare Services Limited's latest financial performance?
Artemis Medicare Services Limited's trailing-twelve-month (TTM) revenue as of 2026-06-30 is ₹1,114 Cr, with a TTM profit after tax of ₹114 Cr and an EBITDA margin of 16.06%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹7.19, with a 5-year EPS growth rate of 33.2% - a rough proxy for how consistently the company has grown per-share earnings over a full market cycle.
What is Artemis Medicare Services Limited's quality score?
Artemis Medicare Services Limited has a Punji quality score of 81.8 out of 100 as of 2026-06-30. This composite score is computed from the company's reported fundamentals (profitability, balance-sheet strength, and consistency of earnings, among other factors) and is designed to be comparable across companies in different sectors. A higher score indicates a fundamentally stronger business by these measures, though it isn't a price target or a buy/sell signal - a high-quality company can still be expensively priced, and a lower-scoring one can still be a reasonable investment at the right valuation.
What do Artemis Medicare Services Limited's technical indicators show?
As of 2026-10-29, Artemis Medicare Services Limited's RSI (14-day) is 41.15 - readings above 70 typically signal an overbought stock, below 30 an oversold one, so this reading sits in neutral territory. Its 50-day moving average is currently above its 200-day moving average, a "golden cross" setup when the shorter average is above (often read as a bullish medium-term signal) or a "death cross" when below (often read as bearish). These are backward-looking statistical measures, not predictions of future price movement.
Who are the major shareholders of Artemis Medicare Services Limited?
As of 2026-06-30, Artemis Medicare Services Limited's shareholding is split across Promoter (58.39%), Public (41.61%). Promoter holding of 58.39% indicates the founders/controlling group's own stake in the company - a higher promoter holding is often read as a sign of management's confidence in the business, though it should be considered alongside pledge status and recent buying/selling activity, which this figure alone doesn't capture.
Has Artemis Medicare Services Limited seen any recent bulk or block deals?
Yes, as of 2026-09-25 - the most recent recorded deal was a BULK on 2026-09-25 for 10,04,061 shares. Bulk and block deals are large trades (above exchange-defined thresholds) that must be publicly disclosed, and are often watched as a signal of institutional or high-net-worth investor conviction - though a single deal doesn't establish a trend, and the counterparty's reasons for buying or selling aren't disclosed alongside the trade itself.
What corporate actions has Artemis Medicare Services Limited announced recently?
The most recent corporate action for Artemis Medicare Services Limited is a SPLIT (0.100000) with an ex-date of 2021-09-23, for: FACE VALUE SPLIT (SUB-DIVISION) - FROM RS 10/- PER SHARE TO RE 1/- PER SHARE. The ex-date is the cutoff - only shareholders who held the stock before this date qualify for the action (dividend, split, bonus, or rights issue, depending on type). Corporate actions typically adjust the stock's price and/or share count mechanically on the ex-date, which is why historical price charts are usually shown adjusted for these events.
Stock data · Not financial advice · Past performance does not indicate future returns